LGALS9 and glioblastoma: THP-1 macrophages treated with conditioned media from U87 glioblastoma Gal-9 KD cell cultures showed reduced CD163 and CD206 M2 marker expression and migration rate compared with THP-1 cells in control media, highlighting tumor-derived Gal-9 as a suppressor of macrophage immunity [146].